TriSalus Life Sciences, Inc.
Price Action
Technical Summary
CONSOLIDATINGTriSalus Life Sciences, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 32), showing significant lag compared to the market leaders. Earnings growth of 108% provides fundamental context to the price action. However, price is extended 21% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $3.77 | +25.47% | ABOVE |
| 50 SMA | $3.90 | +21.42% | ABOVE |
| 100 SMA | $4.18 | +13.13% | ABOVE |
| 150 SMA | $4.87 | -2.88% | BELOW |
| 200 SMA | $4.83 | -2.00% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is TLSI in an uptrend right now?
TLSI has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is TLSI overbought or oversold?
TLSI's RSI (14) is 62. The stock is in neutral territory, neither overbought nor oversold.
Is TLSI outperforming the market?
TLSI has a Relative Strength (RS) Rating of 32 out of 99. TLSI is currently lagging the broader market.
Where is TLSI in its 52-week range?
TLSI is trading at $4.73, which is 59% of its 52-week high ($7.95) and 44% above its 52-week low ($2.22).
How volatile is TLSI?
TLSI has a Beta of 1.32 and 52-week volatility of 81%. It's more volatile than the S&P 500 - expect bigger swings.